1,3-dipropyl-8-cyclopentylxanthine and sk&f-38393

1,3-dipropyl-8-cyclopentylxanthine has been researched along with sk&f-38393 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
di Chiara, G; Morelli, M; Pinna, A; Wardas, J1
Reinart, R; Rinken, A; Uustare, A1
Cao, Y; Jin, L; Sun, WC; Xie, KQ; Zhu, XZ1
Cao, Y; Xie, KQ; Zhu, XZ1

Other Studies

6 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and sk&f-38393

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats.
    The European journal of neuroscience, 1996, Volume: 8, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Denervation; Male; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Proto-Oncogene Proteins c-fos; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation; Triazoles; Xanthines

1996
Modulation of dopamine D1 receptor signaling by adenosine A1 receptors in Sf9 cells requires expression of Gi proteins.
    Neuroscience letters, 2006, Oct-09, Volume: 406, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Benzazepines; Binding, Competitive; Cell Line; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Radioligand Assay; Receptor, Adenosine A1; Receptors, Dopamine D1; Signal Transduction; Spodoptera; Transfection; Tritium; Xanthines

2006
Activation of adenosine A1 receptor modulates dopamine D1 receptor activity in stably cotransfected human embryonic kidney 293 cells.
    European journal of pharmacology, 2006, Oct-24, Volume: 548, Issue:1-3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Alkaline Phosphatase; Benzazepines; Cell Line; Cyclic AMP Response Element-Binding Protein; DNA, Complementary; Dopamine Agonists; Dopamine Antagonists; Humans; Receptor, Adenosine A1; Receptors, Dopamine D1; Transfection; Xanthines

2006
The enhancement of dopamine D1 receptor desensitization by adenosine A1 receptor activation.
    European journal of pharmacology, 2007, May-07, Volume: 562, Issue:1-2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Binding, Competitive; Cell Line; Cyclic AMP; Dopamine Agonists; Drug Synergism; Humans; Receptor, Adenosine A1; Receptors, Dopamine D1; Time Factors; Transfection; Xanthines

2007